SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

Haematologica

Volumn 94, Issue 11, 2009, Pages 1555-1562

  Mozos, Ana ^a   Royo, Cristina ^a   Hartmann, Elena ^b   De Jong, Daphne ^c   Baró, Cristina ^d   Valera, Alexandra ^a   Fu, Kai ^e   Weisenburger, Dennis D ^e   Delabie, Jan ^f   Chuang, Shih Sung ^g   Jaffe, Elaine S ^h   Ruiz Marcellan, Carmen ⁱ   Dave, Sandeep ^j   Rimsza, Lisa ^k   Braziel, Rita ^l   Gascoyne, Randy D ^m   Solé, Francisco ^d   López Guillermo, Armando ^a   Colomer, Dolors ^a   Staudt, Louis M ^h   Rosenwald, Andreas ⁿ   Ott, German ⁿ   Jares, Pedro ^a   Campo, Elias ^a   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d HOSPITAL DEL MAR   (Spain)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g CHI MEI MEDICAL CENTER   (Taiwan)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^j DUKE UNIVERSITY   (United States)

^k UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^l OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^m UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁿ ROBERT BOSCH HOSPITAL   (Germany)

more..

Author keywords

Cyclin D1; Mantle cell lymphoma; SOX11

Indexed keywords

BLEOMYCIN; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MESSENGER RNA; PREDNISONE; RITUXIMAB; TENIPOSIDE; TRANSCRIPTION FACTOR SOX11; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

EID: 70449435195     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010264     Document Type: Article

References (26)

1. Salaverria I, Perez-Galan P, Colomer D, Campo E. Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 2006;91:11-16 (Pubitemid 43235380)
2. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-762 (Pubitemid 47463673)
3. Beà S, Ribas M, Hernández JM, Bosch F, Pinyol M, Hernández L, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999;93:4365-4374 (Pubitemid 29279280)
4. Katzenberger T, Kienle D, Stilgenbauer S, Höller S, Schilling C, Mäder U, et al. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis. Br J Haematol 2008;142:538-550 (Pubitemid 352020198)
5. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V, et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007;109: 271-280 (Pubitemid 46053067)
6. Salaverria I, Espinet B, Carrió A, Costa D, Astier L, Slotta-Huspenina J, et al. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques. Genes Chromosomes Cancer 2008; 47:1086-1097
7. Sander S, Bullinger L, Leupolt E, Benner A, Kienle D, Katzenberger T, et al. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica 2008;93: 680-687
8. Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 2000;95:2253-2261 (Pubitemid 30167722)
9. Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106:4315-4321 (Pubitemid 41775942)
10. Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 2007;25: 1216-1222 (Pubitemid 46640567)
11. Bea S, Campo E. Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior. Haematologica 2008;93:641-645 (Pubitemid 351669301)
12. Wlodarska I, Dierickx D, Vanhentenrijk V, Van Roosbroeck K, Pospísilová H, Minnei F, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;111:5683-5690
13. Gesk S, Klapper W, Martín-Subero JI, Nagel I, Harder L, Fu K, et al. A chromosomal translocation in cyclin D1- negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus. Blood 2006; 108:1109-1110 (Pubitemid 44154656)
14. Herens C, Lambert F, Quintanilla- Martinez L, Bisig B, Deusings C, de Leval L. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14) (p13;q32) and cyclin D2 overexpression. Blood 2008;111:1745-1746 (Pubitemid 351213474)
15. Rizzatti EG, Falcão RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK, et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3KAKT, WNT and TGFβ signalling pathways. Br J Haematol 2005;130:516-526 (Pubitemid 43899754)
16. Ek S, Dictor M, Jerkeman M, Jirström K, Borrebaeck CA. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 2008;111:800-805
17. Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, et al. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 2008;143:248-252
18. Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int 2006;56:440-448 (Pubitemid 44035909)
19. Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001;98:2837-2844
20. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197 (Pubitemid 37443390)
21. De Oliveira MS, Jaffe ES, Catovsky D. Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol 1989;42:962-972 (Pubitemid 19225458)
22. Isaacson PG, Wotherspoon AC, Diss T, Pan LX. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol 1991;15:819-828
23. Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003;120:760-766 (Pubitemid 37339685)
24. Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES. Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 1999;23:59-68. (Pubitemid 29025241)
25. Camacho FI, García JF, Cigudosa JC, Mollejo M, Algara P, Ruíz-Ballesteros E, et al. Aberrant Bcl6 protein expression in mantle cell lymphoma. Am J Surg Pathol 2004;28:1051-1056 (Pubitemid 38971430)
26. Zanetto U, Dong H, Huang Y, Zhang K, Narbaitz M, Sapia S, et al. Mantle cell lymphoma with aberrant expression of CD10. Histopathology 2008;53:20-29 (Pubitemid 351861982)